Leadmuta

Overview

Leadmuta develops small-molecule drugs using AI.

Funding · 2

Amounts as reported; USD estimates shown only when they match

Listed 2 funding records.

Annual trendUnit: USD

No chartable funding estimates yet.

2 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors	Sources
Oct 15, 2024	Undisclosed · Strategic	西大创星	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 西大创星
Aug 26, 2022	Tens of millions of RMB · Angel	元禾厚望, 奉晗投资, 恒利信达, 拓华资本, 杭州网鼎, 正轩投资, 深圳市科三汇投资有限公司, 瑞丰信安, 苏州南慧科技创新研究院, 苏高新创投集团, 长禾资本	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 元禾厚望, 奉晗投资, 恒利信达, 拓华资本, 杭州网鼎, 正轩投资, 深圳市科三汇投资有限公司, 瑞丰信安, 苏州南慧科技创新研究院, 苏高新创投集团, 长禾资本

Select ▸ on a row to see its source brief and links.

Valuation · 2

Amounts as reported; USD estimates shown only when they match

Listed 2 valuation records.

Annual trendUnit: USD

No chartable valuation estimates yet.

2 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors	Sources
Oct 15, 2024	— · Strategic	西大创星	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 西大创星
Aug 26, 2022	— · Angel	元禾厚望, 奉晗投资, 恒利信达, 拓华资本, 杭州网鼎, 正轩投资, 深圳市科三汇投资有限公司, 瑞丰信安, 苏州南慧科技创新研究院, 苏高新创投集团, 长禾资本	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 元禾厚望, 奉晗投资, 恒利信达, 拓华资本, 杭州网鼎, 正轩投资, 深圳市科三汇投资有限公司, 瑞丰信安, 苏州南慧科技创新研究院, 苏高新创投集团, 长禾资本

Select ▸ on a row to see its source brief and links.

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Sources · 0

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

AI小分子药物研发商立妙达是一家AI小分子药物研发商